Forgot Password

Please enter your email below.*
To create your new password, please enter your email address below.
We will send an email with instructions to reset your password.
*It must be the same email you used to register for your account

Earn 6.75 live CE credits at this full day virtual pharmacy conference!

This live program will be broadcast virtually on 4 dates.
Click on an icon to view more details and register:

Join our interactive broadcast!

Broaden your horizon this fall!

We invite you to attend our Directions in Oncology Pharmacy fall conference virtually! Our interactive sessions include expert faculty speakers who will share the latest clinical data while exploring best practices and management strategies. This year’s program will help pharmacists in a variety of practice settings to optimize the coordination of care of their patients.

The Virtual Experience
Directions in Oncology Pharmacy® 2020 Overview

Rapidly evolving use of immunotherapies and targeted therapies has changed the landscape for anticancer treatment. The complexity of new regimens and the need for coordination of care across practice and pharmacy settings has reinforced and expanded the roles of pharmacists both clinically and operationally. It is essential for pharmacists across settings to understand the different treatment options and dosing regimens, implement methods to improve patient adherence, educate other health care team members, and counsel patients during onboarding and ongoing treatment to manage potential adverse effects associated with these agents to optimize patient care and outcomes. This full-day educational meeting will provide live practical education to pharmacists in the inpatient, ambulatory, oncology, infusion, and specialty pharmacy practice settings. Sessions will focus on evolving treatment strategies, including use of checkpoint inhibitors and targeted oral and infusional therapies for the care of patients with solid tumors and hematologic malignancies, with a focus on topics such as multiple myeloma and B-cell malignancies as well as breast, lung, and gynecologic cancers.

Educational Objectives for Attending Oncology Pharmacists

Upon completion of this knowledge-based educational conference, pharmacists should be able to:
  • Examine recently approved and expanded indications for immunotherapies and targeted therapies, including evidence for use based on biomarkers as well as efficacy and safety
  • Analyze current hematologic and solid malignancy guidelines, including for multiple myeloma and breast, lung, and gynecologic cancers, for how evolving agents fit into the treatment paradigm
  • Identify the role of pharmacists in managing adverse effects, educating the health care team and patients, improving patient adherence, and coordinating care to improve patient outcomes

Target Audience
This continuing education program is directed toward pharmacists practicing in oncology, health-system, specialty pharmacy, outpatient clinic, infusion center, and retail settings.

Acknowledgment of Commercial Support
Directions in Oncology Pharmacy is supported by educational grants from Bristol Myers Squibb; Daiichi Sankyo, Inc.; Eisai; GlaxoSmithKline; Merck Sharp & Dohme Corp; Pharmacyclics LLC., an AbbVie Company and Janssen Biotech, Inc.; and Seattle Genetics, Inc.

Topics will include:

  • Metastatic breast cancer
  • Non-small cell lung cancer
  • B-cell malignancies
  • Multiple myeloma
  • Acute graft-versus-host disease
  • Cervical and endometrial cancers
  • Cancer care in the era of COVID-19

Follow us on social media! #DI0P2020

Overview of 2020 Agenda

This year’s virtual agenda focuses on evolving treatment strategies, including use of checkpoint inhibitors and targeted oral and infusional therapies for the care of patients with solid tumors and hematologic malignancies, with a focus on topics such as multiple myeloma and B-cell malignancies as well as breast, lung, and gynecologic cancers.

Directions in Oncology Pharmacy
8:00 am – 8:15 am


Jim Palatine, RPh, MBA

Pharmacy Times Continuing Education

Larry Buie, PharmD, BCOP, FASHP

Clinical Pharmacy Manager, BMT and Lymphoma
Residency Program Director
Memorial Sloan Kettering Cancer Center
New York, New York

8:15 am – 9:00 am

COVID-19 and Impact to Patients With Cancer

David DeRemer, PharmD, BCOP, FCCP, FHOPA

Clinical Associate Professor
Assistant Director Experimental Therapeutics
University of Florida College of Pharmacy
University of Florida Health Cancer Center
Gainesville, Florida

9:00 am – 9:45 am

B-Cell Malignancies: Exploring the Influence of BTK Inhibitors and Pharmacist-Led Interventions on Patient Outcomes

Kirollos S. Hanna, PharmD, BCPS, BCOP

Oncology Pharmacy Manager
M Health Fairview, Maple Grove
Assistant Professor of Pharmacy
Mayo Clinic College of Medicine
Rochester, Minnesota

9:45 am – 10:00 am


10:00 am – 10:45 am 

Breast Cancer: a Focus on Oral Chemotherapeutic Formulations for Pharmacists in the Ambulatory Care Setting

Jason Bergsbaken, PharmD, BCOP

Pharmacy Coordinator
Regional Oncology Services
UW Health
Madison, Wisconsin

10:45 am – 11:30 am

HER2-Directed Therapy in Metastatic Breast Cancer: Pharmacist Involvement to Optimize Care

Allison Butts, PharmD, BCOP

Clinical Coordinator, Oncology Pharmacy
UK HealthCare
Assistant Adjunct Professor
UK College of Pharmacy
Lexington, Kentucky

11:30 am – 12:15 pm

Cervical and Endometrial Cancers: A Pharmacist's Review of the New and Emerging Treatment Paradigm for Patients with Advanced or Metastatic Disease


Director of Women's Health Integrative Medicine Research Program
Division of Gynecologic Oncology
Department of Obstetrics, Gynecology & Reproductive Sciences
McGovern Medical School at UTHealth
Houston, Texas

12:15 pm – 12:45 pm


12:45 pm – 1:30 pm

Acute Graft Versus Host Disease: Innovative Strategies in Risk Assessment, Prevention, and Treatment

To Be Announced

1:30 pm – 2:15 pm

PARP Inhibition: Current and Emerging Indications for Use in Ovarian, Breast, Pancreatic, and Prostate Cancers

To Be Announced

2:15 pm – 2:30 pm


2:30 pm – 3:15 pm

Multiple Myeloma: Exploring the Rapidly Evolving Treatment Landscape for Relapsed or Refractory Disease

Kathryn Maples, PharmD, BCOP

Clinical Pharmacy Specialist, Multiple Myeloma
Emory Healthcare, Winship Cancer Institute
Atlanta, Georgia

3:15 pm – 4:00 pm 

Advances in Managing Metastatic Non-Small Cell Lung Cancer in the Era of Immune Checkpoint Inhibitors

Eve Segal, PharmD, BCOP

Lead Clinical Pharmacist, Hematology/Oncology
Seattle Cancer Care Alliance
University of Washington Medical Center
Seattle, Washington

4:00 pm – 4:30 pm

Closing Remarks

  Meeting information is accurate at the time of posting.

*Agenda including specific topics, session times and associated faculty are actively evolving and will continue to be updated


This year PTCE will be bringing Directions in Oncology Pharmacy to you virtually! We value your education above all and have committed ourselves to providing CE in an engaging, interactive, and easily-accessible way. During these full-day virtual meetings, you will be able to view live presentations, participate in polling, save slides, and ask the faculty questions all from the comfort of your home. We look forward to you joining us on our new virtual platform for Directions in Oncology Pharmacy 2020!

Follow us on social media! #DI0P2020

To register for an event, a PharmacyTimes account is required. Please create one or if you already have one, please choose a virtual session below:

Saturday, September 26, 2020

register for new york

Saturday, October 10, 2020

register for new york

Saturday, October 24, 2020
West Coast

register for new york

Saturday, November 7, 2020

register for new york

Follow us on social media! #DIOP2020

Personalize the information you receive by selecting targeted content and special offers.